Post-transplant plasma cell hepatitis in a liver transplant patient treated with pegylated interferon plus ribavirin
| Autor: | Francisco Javier Rando-Muñoz, Fernando González-Panizo Tamargo, Jesús de la Cruz Lombardo, Rocío González-Grande, Juan Miguel Rodrigo López, Román Manteca González, Miguel Jiménez-Pérez |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Hepatitis
medicine.medical_specialty business.industry medicine.medical_treatment Ribavirin Hepatitis C Plasma cell Liver transplantation medicine.disease Gastroenterology Post transplant chemistry.chemical_compound medicine.anatomical_structure chemistry Pegylated interferon Internal medicine Immunology Medicine Transplant patient business medicine.drug |
| Zdroj: | Open Journal of Gastroenterology. :307-310 |
| ISSN: | 2163-9469 2163-9450 |
| Popis: | The recurrence of hepatitis C after a liver transplant remains an important cause of graft loss and retransplant. Antiviral therapy with peginterferon plus ribavirin (PEG-INF/RBV) can achieve a sustained viral response and histological improvement in a high percentage of cases. However, this treatment is not exempt from important side effects or from the possibility of precipitating rejection, with the resulting graft loss. We report the case of a liver transplant patient who received treatment with PEG-INF/RBV and developed plasma cell hepatitis as the presenting form of rejection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|